Werbung
Kursziele der Sanofi-Aktie
*Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Sanofi-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Deutsche Bank AG | 85,00€ | +9,16% | 21.09.22 | |
| Credit Suisse Group | 106,00€ | +36,12% | 15.09.22 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 91,00€ | +16,86% | 14.09.22 | |
| Jefferies & Company Inc. | 110,00€ | +41,26% | 08.09.22 | |
| JP Morgan Chase & Co. | - | - | 06.09.22 | |
| Barclays Capital | 104,43€ | +34,11% | 30.08.22 | |
| Goldman Sachs Group Inc. | 130,00€ | +66,94% | 18.08.22 | |
| UBS AG | 103,00€ | +32,27% | 09.08.22 | |
| Bernstein Research | 130,00€ | +66,94% | 28.07.22 | |
| Kepler Cheuvreux | 105,00€ | +34,84% | 02.12.21 | |
| Morgan Stanley | 106,00€ | +36,12% | 28.10.21 |
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| Amgen Inc. | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 5 | 3 | 1 | 107,06 £ | - |
| Bayer | 12 | 1 | 0 | 78,75 € | +63,25% |
| BioNTech (ADRs) | 1 | 6 | 0 | 223,86 $ | - |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 0 | 0 | - | - |
| EVOTEC SE | 5 | 0 | 1 | 37,17 € | +113,13% |
| GSK PLC Registered Shs | 2 | 8 | 0 | 16,59 £ | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 5 | 1 | 213,18 € | +35,27% |
| Moderna Inc | 0 | 0 | 0 | - | - |
| MorphoSys | 2 | 4 | 0 | 43,92 € | +140,13% |
| Mylan N.V. | 0 | 0 | 0 | - | - |
| Novartis AG | 2 | 4 | 4 | 86,60 CHF | - |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 1 | 4 | 0 | 52,00 $ | +17,78% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 7 | 4 | 0 | 107,04 € | +37,46% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 2 | 0 | 0 | 25,75 € | +353,35% |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |